- Datasheet
- Specific References (4)
- Protocols
Overview
-
Product nameAnti-XIAP antibody
See all XIAP primary antibodies -
DescriptionRabbit polyclonal to XIAP
-
SpecificityThis antibody detects the 53 kDa human XIAP protein. It does not cross-react with other apoptosis inhibitors.
-
Tested applicationsSuitable for: IHC (PFA fixed), WB, ICC/IFmore details
-
Species reactivityReacts with: Mouse, Rat, Human
-
Immunogen
Available on request. (Peptide available as ab38275.)
Properties
-
FormLiquid
-
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
-
Storage bufferPreservative: 0.01% Thimerosal (merthiolate)
Constituents: 30% Glycerol, 0.5% BSA, PBS, pH 7.2 -
Concentration information loading... -
PurityImmunogen affinity purified
-
ClonalityPolyclonal
-
IsotypeIgG
-
Research areas
Associated products
-
Compatible Secondaries
-
Immunizing Peptide (Blocking)
-
Related Products
Applications
Our Abpromise guarantee covers the use of ab2541 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| IHC (PFA fixed) | Use at an assay dependent concentration. PubMed: 17094439 | |
| WB | Use a concentration of 1 µg/ml. Detects a band of approximately 54 kDa (predicted molecular weight: 54 kDa).Can be blocked with XIAP peptide (ab38275). | |
| ICC/IF | 1/200. |
Target
-
FunctionApoptotic suppressor. Has E3 ubiquitin-protein ligase activity. Mediates the proteasomal degradation of target proteins, such as caspase-3, SMAC or AIFM1. Inhibitor of caspase-3, -7 and -9. Mediates activation of MAP3K7/TAK1, leading to the activation of NF-kappa-B.
-
Tissue specificityUbiquitous, except peripheral blood leukocytes.
-
Involvement in diseaseDefects in XIAP are the cause of lymphoproliferative syndrome X-linked type 2 (XLP2) [MIM:300635]. XLP is a rare immunodeficiency characterized by extreme susceptibility to infection with Epstein-Barr virus (EBV). Symptoms include severe or fatal mononucleosis, acquired hypogammaglobulinemia, pancytopenia and malignant lymphoma.
-
Sequence similaritiesBelongs to the IAP family.
Contains 3 BIR repeats.
Contains 1 RING-type zinc finger. -
DomainThe first BIR domain is involved in interaction with TAB1/MAP3K7IP1 and is important for dimerization. The second BIR domain is sufficient to inhibit caspase-3 and caspase-7, while the third BIR is involved in caspase-9 inhibition. The interactions with SMAC and PRSS25 are mediated by the second and third BIR domains.
-
Post-translational
modificationsUbiquitinated and degraded by the proteasome in apoptotic cells.
Phosphorylation by PKB/AKT protects XIAP against ubiquitination and protects the protein against proteasomal degradation. -
Cellular localizationCytoplasm.
- Information by UniProt
-
Database links
- Entrez Gene: 331 Human
- Entrez Gene: 11798 Mouse
- Entrez Gene: 63879 Rat
- Omim: 300079 Human
- SwissProt: P98170 Human
- SwissProt: Q60989 Mouse
- SwissProt: Q9R0I6 Rat
- Unigene: 356076 Human
see all -
Alternative names
- AP 13 antibody
- API3 antibody
- Apoptosis Inhibitor 3 antibody
see all
Anti-XIAP antibody images
-
Immunocytochemistry/ Immunofluorescence - Anti-XIAP antibody (ab2541)This image is courtesy of an Abreview submitted by Dr Kirk McManusab2541 (1/200) staining XIAP in HeLa cells (green). Cells were permeabilised with 0.5% Triton-X100/ PBS, fixed in methanol (-20oC, 10min) and counterstained with DAPI (red) in order to highlight the nucleus. Please refer to abreview for further experimental details. -
Western blot - Anti-XIAP antibody (ab2541)All lanes : Anti-XIAP antibody (ab2541) at 1 µg/ml
Lane 1 : Human brain tissue lysate - total protein (ab29466)
Lane 2 : Human placenta tissue lysate - total protein (ab29745)
Lysates/proteins at 10 µg per lane.
Secondary
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Developed using the ECL technique
Performed under reducing conditions.
Predicted band size : 54 kDa
Observed band size : 54 kDa
Exposure time : 12 minutes -
Immunocytochemistry/ Immunofluorescence - Anti-XIAP antibody (ab2541)ab2541 staining XIAP in MCF7 cells treated with forskolin (ab120058), by ICC/IF. Increase in XIAP expression correlates with increased concentration of forskolin, as described in literature.
The cells were incubated at 37°C for 2h in media containing different concentrations of ab120058 (forskolin) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab2541 (1 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody.
Protocols
References for Anti-XIAP antibody (ab2541)
This product has been referenced in:
- Zhang QY et al. FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells. Sci Rep 7:396 (2017). WB ; Human . Read more (PubMed: 28341836) »
- Hsu KH et al. Anti-apoptotic effects of osteopontin through the up-regulation of Mcl-1 in gastrointestinal stromal tumors. World J Surg Oncol 12:189 (2014). WB ; Human . Read more (PubMed: 24947165) »
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"